Company performance
Current Price
as of Jan 07, 2025$1.72
P/E Ratio
N/A
Market Cap
$215.97M
Loading...
Description
Nautilus Biotechnology, Inc. is a life sciences company, which engages in the development of a proteomics platform for analyzing and quantifying the human proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in Seattle, WA.
Metrics
Overview
- HQSeattle, WA
- SectorHealth Technology
- IndustryBiotechnology
- TickerNAUT
- Price$1.72-1.15%
Trading Information
- Market cap$215.97M
- Float45.79%
- Average Daily Volume (1m)164,577
- Average Daily Volume (3m)130,694
- EPS-$0.56
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$16.45M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$17.49M
- EV$248.50M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B0.97
Documents
SEC Filings
Earnings Calls
Factset